Below are the most recent publications written about "Naloxone" by people in Profiles.
-
Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings. Ann Emerg Med. 2024 07; 84(1):20-28.
-
Quintanilla ME, Morales P, Santapau D, ?vila A, Ponce C, Berrios-C?rcamo P, Olivares B, Gallardo J, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F. Chronic Voluntary Morphine Intake Is Associated with Changes in Brain Structures Involved in Drug Dependence in a Rat Model of Polydrug Use. Int J Mol Sci. 2023 Dec 03; 24(23).
-
Quezada M, Ponce C, Berr?os-C?rcamo P, Santapau D, Gallardo J, De Gregorio C, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M, Israel Y, Andr?s-Herrera P, Hip?lito L, Ezquer F. Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence. CNS Neurosci Ther. 2024 04; 30(4):e14517.
-
Kusic DM, Heil J, Zajic S, Brangan A, Dairo O, Heil S, Feigin G, Kacinko S, Buono RJ, Ferraro TN, Rafeq R, Haroz R, Baston K, Bodofsky E, Sabia M, Salzman M, Resch A, Madzo J, Scheinfeldt LB, Issa JJ, Jelinek J. Postmortem toxicology findings from the Camden Opioid Research Initiative. PLoS One. 2023; 18(11):e0292674.
-
Deutsch SA, De Jong AR. Xylazine Complicating Opioid Ingestions in Young Children. Pediatrics. 2023 01 01; 151(1).
-
Terashvili M, Talluri B, Palangmonthip W, Iczkowski KA, Sanvanson P, Medda BK, Banerjee B, Cunningham CW, Sengupta JN. Peripheral antinociceptive effects of a bifunctional ? and d opioid receptor ligand in rat model of inflammatory bladder pain. Neuropharmacology. 2021 09 15; 196:108701.
-
Freibott CE, Walker A, Maio V, Frasso R. Educational programs implemented for pharmacists after state passage of a standing order for naloxone: A systematic review of current practices. J Am Pharm Assoc (2003). 2021 May-Jun; 61(3):e19-e27.
-
Lowenstein M, Feuerstein-Simon R, Dupuis R, Herens A, Hom J, Sharma M, Sheni R, Encarnacion L, Flaherty C, Cueller M, Cannuscio C. Overdose Awareness and Reversal Trainings at Philadelphia Public Libraries. Am J Health Promot. 2021 02; 35(2):250-254.
-
Herbert N, Axson S, Siegel L, Cassidy K, Hoyt-Brennan AM, Whitney C, Herens A, Giordano NA. Leveraging immersive technology to expand access to opioid overdose reversal training in community settings: Results from a randomized controlled equivalence trial. Drug Alcohol Depend. 2020 09 01; 214:108160.
-
Nugent K, Matthews P, Gissendaner J, Papas M, Occident D, Patel A, Johnson M, Megargel RE, Nomura JT. A Comparison of Efficacy of Treatment and Time to Administration of Naloxone by BLS and ALS Providers. Prehosp Disaster Med. 2019 Aug; 34(4):350-355.